S Migasena

843 total citations
39 papers, 666 citations indexed

About

S Migasena is a scholar working on Parasitology, Epidemiology and Infectious Diseases. According to data from OpenAlex, S Migasena has authored 39 papers receiving a total of 666 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Parasitology, 10 papers in Epidemiology and 7 papers in Infectious Diseases. Recurrent topics in S Migasena's work include Parasites and Host Interactions (8 papers), Vibrio bacteria research studies (7 papers) and Salmonella and Campylobacter epidemiology (5 papers). S Migasena is often cited by papers focused on Parasites and Host Interactions (8 papers), Vibrio bacteria research studies (7 papers) and Salmonella and Campylobacter epidemiology (5 papers). S Migasena collaborates with scholars based in Thailand, United States and Netherlands. S Migasena's co-authors include Pravan Suntharasamai, P Pitisuttitham, H. M. Gilles, P. A. J. Ball, T Harinasuta, D Bunnag, Wichai Supanaranond, Varunee Desakorn, Sriluck Simasathien and Dwip Kitayaporn and has published in prestigious journals such as Journal of Clinical Microbiology, The Journal of Infectious Diseases and Infection and Immunity.

In The Last Decade

S Migasena

39 papers receiving 638 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Migasena Thailand 15 235 171 143 137 104 39 666
A. J. H. Tomlinson United Kingdom 15 271 1.2× 145 0.8× 76 0.5× 21 0.2× 39 0.4× 36 704
Jane Greatorex United Kingdom 16 279 1.2× 147 0.9× 77 0.5× 201 1.5× 18 0.2× 28 707
Darwin J. Operario United States 21 443 1.9× 212 1.2× 40 0.3× 75 0.5× 123 1.2× 32 940
Fred R. McCrumb United States 16 233 1.0× 190 1.1× 33 0.2× 124 0.9× 120 1.2× 26 815
J T LaBrooy Australia 20 358 1.5× 219 1.3× 208 1.5× 43 0.3× 13 0.1× 42 1.0k
Maherisoa Ratsitorahina Madagascar 14 198 0.8× 206 1.2× 68 0.5× 82 0.6× 114 1.1× 34 718
T. Schuurman Netherlands 14 389 1.7× 320 1.9× 164 1.1× 36 0.3× 165 1.6× 16 853
Hongxiong Guo China 15 299 1.3× 242 1.4× 36 0.3× 202 1.5× 27 0.3× 51 618
L.K. Nagy United Kingdom 15 91 0.4× 66 0.4× 65 0.5× 36 0.3× 27 0.3× 25 457
Alena Atrasheuskaya Russia 13 409 1.7× 206 1.2× 61 0.4× 41 0.3× 28 0.3× 19 745

Countries citing papers authored by S Migasena

Since Specialization
Citations

This map shows the geographic impact of S Migasena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Migasena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Migasena more than expected).

Fields of papers citing papers by S Migasena

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Migasena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Migasena. The network helps show where S Migasena may publish in the future.

Co-authorship network of co-authors of S Migasena

This figure shows the co-authorship network connecting the top 25 collaborators of S Migasena. A scholar is included among the top collaborators of S Migasena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Migasena. S Migasena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pitisuttithum, Punnee, Phillip W. Berman, Benjaluck Phonrat, et al.. (2004). Phase I/II Study of a Candidate Vaccine Designed Against the B and E Subtypes of HIV-1. JAIDS Journal of Acquired Immune Deficiency Syndromes. 37(1). 1160–1165. 50 indexed citations
2.
Migasena, S, Pravan Suntharasamai, Punnee Pitisuttithum, et al.. (2000). AIDSVAX ® (MN) in Bangkok Injecting Drug Users: A Report on Safety and Immunogenicity, Including Macrophage-Tropic Virus Neutralization. AIDS Research and Human Retroviruses. 16(7). 655–663. 31 indexed citations
3.
Migasena, S, Sriluck Simasathien, P Pitisuttitham, et al.. (1998). Adverse impact of infections on antibody responses to measles vaccination. Vaccine. 16(6). 647–652. 10 indexed citations
4.
Migasena, S, D. Gray Heppner, Dennis E. Kyle, et al.. (1997). SPf66 malaria vaccine is safe and immunogenic in malaria naive adults in Thailand. Acta Tropica. 67(3). 215–227. 12 indexed citations
5.
Simasathien, Sriluck, S Migasena, William J. Bellini, et al.. (1997). Measles vaccination of Thai infants by intranasal and subcutaneous routes: possible interference from respiratory infections. Vaccine. 15(3). 329–334. 8 indexed citations
6.
Pitisuttithum, Punnee, et al.. (1997). Risk behaviours and comprehension among intravenous drug users volunteered for HIV vaccine trial.. PubMed. 80(1). 47–50. 7 indexed citations
7.
Migasena, S, Sriluck Simasathien, Rudiwilai Samakoses, et al.. (1995). Simultaneous administration of oral rhesus-human reassortant tetravalent (RRV-TV) rotavirus vaccine and oral poliovirus vaccine (OPV) in Thai infants. Vaccine. 13(2). 168–174. 37 indexed citations
8.
Simasathien, Sriluck, S Migasena, P Pitisuttitham, et al.. (1994). Vaccination of Thai infants with rhesus-human reassortant tetravalent oral rotavirus vaccine. The Pediatric Infectious Disease Journal. 13(7). 590–596. 12 indexed citations
9.
Simasathien, Sriluck, S Migasena, Coen Beuvery, et al.. (1994). Comparison of Enhanced Potency Inactivated Poliovirus Vaccine (EIPV) Versus Standard Oral Poliovirus Vaccine (OPV) in Thai Infants. Scandinavian Journal of Infectious Diseases. 26(6). 731–738. 12 indexed citations
10.
Suntharasamai, Pravan, et al.. (1992). Clinical and bacteriological studies of El Tor cholera after ingestion of known inocula in Thai volunteers. Vaccine. 10(8). 502–505. 15 indexed citations
11.
Hoge, Charles W., Andrew F. Trofa, S Migasena, et al.. (1992). Safety and Immunogenicity of Different Immunization Regimens of CVD 103-HgR Live Oral Cholera Vaccine in Soldiers and Civilians in Thailand. The Journal of Infectious Diseases. 165(6). 1042–1048. 82 indexed citations
12.
Migasena, S, H. M. Gilles, & P. A. J. Ball. (1991). Clinical features and diagnosis.. 179–193. 38 indexed citations
13.
Migasena, S, Varunee Desakorn, Pravan Suntharasamai, et al.. (1989). Immunogenicity of two formulations of oral cholera vaccine comprised of killed whole vibrios and the B subunit of cholera toxin. Infection and Immunity. 57(1). 117–120. 17 indexed citations
14.
Changbumrung, Supranee, et al.. (1988). Lipid composition of serum lipoprotein in opisthorchiasis. Annals of Tropical Medicine and Parasitology. 82(3). 263–269. 7 indexed citations
15.
Migasena, S. (1985). Transient total blindness from quinine therapy. Annals of Tropical Medicine and Parasitology. 79(1). 109–110. 1 indexed citations
16.
Migasena, S. (1983). Hypoglycaemia in falciparum malaria. Annals of Tropical Medicine and Parasitology. 77(3). 323–324. 16 indexed citations
17.
Changbumrung, Supranee, et al.. (1982). Alpha 1-antitrypsin, alpha 1-antichymotrypsin and alpha 2-macroglobulin in human liver fluke (opisthorchiasis).. PubMed. 33(3). 195–7. 3 indexed citations
18.
Viravan, C, S Migasena, D Bunnag, & T Harinasuta. (1982). Clinical trial of albendazole in hookworm infection.. PubMed. 13(4). 654–7. 3 indexed citations
19.
Migasena, S, Pravan Suntharasamai, & T Harinasuta. (1978). Mebendazole, tetrachlorethylene and pyrantel pamoate in the treatment of hookworm infection. Annals of Tropical Medicine and Parasitology. 72(2). 199–200. 4 indexed citations
20.
Suntharasamai, Pravan, et al.. (1974). Comparative clinical trials of niclosamide and tetrachlorethylene in the treatment of Fasciolopsis buski infection.. PubMed. 5(4). 556–9. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026